Clinical Trial Update: Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating RELiZORB for managing exocrine pancreatic insufficiency in tube-fed pancreatitis patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency
• Pancreatitis

Drugs mentioned

• RELiZORB

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Exocrine Pancreatic Insufficiency (EPI), Pancreatitis | Phase 3 | Status: RECRUITING